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ABSTRACT
As the HIV population ages and HAART extends the life span of older HIV+ individuals,
it is important to address the neuropsychological, cognitive, and emotional manifestations
of HIV in this sub-population. The purpose of the present study was to examine whether
apathy and depressive symptoms were associated with executive functioning in older
HIV+ individuals. This archival study explored whether four items from the Beck
Depression Inventory, Second Edition (BDI-II) could serve as an index of apathy and
whether higher scores on these items would be related to greater impairment on measures
of executive functioning. The sample consisted of 95 older HIV+ persons who
completed neurocognitive tests of executive functioning as well as the BDI-II as part of
larger study examining the relationship between HIV and aging. The measures of
executive functioning were: the Stroop Color Word Interference Test; the Trail Making
Test, Part B; the Controlled Word Association Test; and the Wisconsin Card Sorting
Test-64. Four items from the BDI-II - reflecting loss of pleasure, loss of interest, loss of
interest in sex, and difficulty making decisions - were selected on the basis of prior
research and rational analysis as likely to represent apathy. Cronbach’s alpha reliability
analysis determined that these four items of the BDI-II clustered together with acceptably
high internal consistency in the present sample (.75). However, overall scores on the
BDI-II, including on the four items thought to reflect apathy, tended to be surprisingly
low, indicating little self-reported depressive symptomatology. Consistent with prior
research, the overall BDI-II showed impressive internal consistency reliability in the
present sample (.92). It was predicted that higher apathy scores would be associated with
poorer performance on measures of executive functioning. The sample was ethnically
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diverse, predominantly male, and had a mean age of 55.26 years. The mean years of
education was 13.67, while the mean estimated level of premorbid intellectual
functioning was 97.73. The results showed there was no significant relationship between
the hypothesized apathy items and executive functioning performance. Moreover,
findings showed no relationship between overall BDI-II scores and performance on
measures of executive functioning. The limitations of this archival study included the
absence of an independent criterion measure for the construct of apathy. Other findings,
additional limitations, and suggestions for future research are discussed.

x

Introduction
Background
The Centers for Disease Control and Prevention (CDC, 2008) estimate that over 1
million individuals in the United States are infected with the human immunodeficiency
virus (HIV). Since the introduction of highly active antiretroviral therapy (HAART),
survival rates associated with HIV have improved dramatically (de Olalla et al., 2002;
Murphy et al., 2001). However, despite advances in the diagnosis and treatment of HIV
infection, most antiviral treatments do not cross the blood-brain barrier (Gartner & Liu,
2002; Gartner, 2000), leaving the CNS vulnerable to the damaging neurotropic effects of
HIV (Ellis, Langford, & Masliah, 2007). With the introduction of HAART, there has
been a greater life expectancy for HIV infected persons, which has ultimately resulted in
a growing population of older HIV+ individuals. Progress in treatment has transformed
HIV from an untreatable illness with a dire prognosis to a more chronic illness with
complex cognitive and neuropsychiatric manifestations (Bornstein et al., 1993a; Gorman,
Foley, Ettenhofer, Hinkin, & van Gorp, 2009; McCombe, Noorbakhsh, Buchholz, Trew,
& Power, 2009; Starace et al., 2002).
Neuropsychological Factors Associated With HIV
Cognitive impairment has been found to occur in 55% to 65% of people with
AIDS and it has been estimated that between 30% and 50% of HIV+ individuals would
experience some form of neurocognitive decline (Heaton et al., 1995). Despite treatment
advances in the post-HAART era and reduced frequency of dementia, milder forms of
cognitive impairment remain frequent (Antinori et al., 2007; Heaton et al., 2010). HIV
infection most prominently affects the cognitive domains of motor functioning, attention,
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processing speed, executive functioning, and memory (Ances & Ellis, 2007; Foley,
Ettenhofer, Wright, & Hinkin, 2008; Heaton et al., 1995; Woods, Moore, Weber, &
Grant, 2009). HIV-related neurocognitive impairment can range from subtle deficits to
marked dementia syndromes that disrupt an individual’s daily functioning, employment,
and ability to manage important tasks such as managing finances and adhering to
medications (Foley et al., 2008; Gorman et al., 2009; Grant, Heaton, & Atkinson, 1995;
Heaton & The HNRC Group, 2004; Hinkin, van Gorp, & Satz, 1995). Although the
specific mechanisms and effects of HIV infiltration of the CNS are not fully understood,
there is research indicating that the frontal-subcortical circuitry is a primary target
(Everall, Luthert, & Lantos, 1991; Heaton et al., 1995; von Giesen, Baecker, Hefter, &
Arendt, 2001). A recent study from Dawes and colleagues (2008) has shown that
executive function impairment is a central characteristic of most HIV neurocognitive
impairment profiles. Executive functions include abstraction, problem solving, set
shifting and reasoning. Because executive functions are dependent on the frontal cortex,
it makes sense that HIV has been found to be associated with executive function
impairment (Reger, Welsh, Razani, Martin, & Boone, 2002). Executive dysfunction has
been found to be associated with functional deficits that include decreased medication
adherence and poorer performance of activities of daily living (Schillerstrom, Horton, &
Royall, 2005).
Neuropsychiatric and Neurocognitive Disorder in Older HIV+ Adults
Currently, more than 15% of all US AIDS patients are older than 50 years (CDC,
2007). With the introduction of more effective treatments, mortality rates have dropped
and HIV has consequently evolved into a disease that is increasingly affecting older
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adults (Valcour et al., 2004). Research findings have supported the hypothesis that older
HIV-infected individuals may be at greater risk for cognitive impairment due to the cooccurrence of both older age and HIV disease (Becker, Lopez, Dew, & Aizenstein, 2004;
Valcour et al., 2004). Given that HIV infection and normal aging processes are risk
factors for neuropsychological compromise, it is not surprising that the older HIV
population is particularly vulnerable to neuropsychological impairment. Research
suggests that the clinical manifestations of infection among older HIV+ individuals are
considerably different than those observed in younger cohorts, because of the increased
risk factors and vulnerability for developing cognitive decline (Foley et al., 2008;
Valcour et al., 2004). It has also been suggested that neuropsychological deficits are
more pronounced in the later stages of HIV infection (Heaton et al., 1995). Therefore,
neuropsychological tests may be important tools for detecting deficits present in an older
HIV population, especially given that older individuals are more likely than younger
persons to exhibit cognitive decline. As the HIV population ages and HAART extends
the life span of older HIV+ individuals, it is important to address the neuropsychological
and cognitive manifestations of HIV in this sub-population. The purpose of the present
study was to examine whether the construct of apathy was associated with executive
dysfunction in a sample of older HIV+ individuals. To the extent that a relationship
could be identified, it was reasoned that apathy may represent a significant
neuropsychiatric indicator of CNS pathology among older HIV+ individuals.
HIV and Depression
Depression is common in individuals with a variety of medical illnesses, and
appears to be more common among HIV+ individuals than the general population (Basu,
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Chwastiak, & Bruce, 2005; Chandra, Desai & Ranjan, 2005; Treisman, Fishman,
Schwartz, Hutton, & Lyketsos, 1998). In the U.S., estimated prevalence of depression is
2-10 times higher in people living with HIV/AIDS compared to the general population
(Bing et al., 2001; Pence, 2009). Bing and colleagues (2001) showed that as many as
37% of HIV-infected individuals suffered from major depression. Despite medical
treatment advances, it remains unclear what factors are contributing to the high
prevalence of depression among those with HIV. While researchers have accumulated
considerable findings regarding the cognitive consequences of HIV infection, less is
known about the neuropsychiatric changes that often surface. The degree to which mood
disturbance may manifest differently in primary psychiatric versus primary neurologic
populations has been under-studied. The extent to which psychiatric features that
accompany HIV, such as depression, anxiety, irritability, and apathy, are a result of
insults to the CNS or secondary to medical, social, and financial stressors remains unclear
(Castellon, Hinkin, & Myers, 2000; Castellon, Hinkin, Wood, & Yarema, 1998; Rabkin
et al., 2000). It has been suggested that the depression associated with HIV is either
idiopathic or induced by the illness through direct or indirect pathways. Idiopathic
depression stems from factors that cause depression in non-medically ill populations,
such as family history of affective disorders, trauma, or adverse life stressors. HIVprovoked depression implies that the mood disorder is either associated with the CNS
infiltration of HIV or a response to increased stressors associated with HIV. Treisman et
al. (1998) suggest that depression may be the result of neurotropic effects of the virus on
the subcortical brain areas that remain vulnerable with HAART treatment. However,
most research has found that among HIV+ individuals, depression and anxiety appear to
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be less related to the neurotropic effects of the disease (Bornstein et al., 1993b; Carter,
Rourke, Murji, Shore, & Rourke, 2003; Castellon et al., 1998; Cole et al., 2007; Heaton
et al., 1995; Judd et al., 2005; Rabkin et al., 2000) and more likely stemming from
secondary factors such as social stigmatization, marginalization, unemployment,
bereavement, compromised social support, and increased medical, legal and financial
stressors (Castellon et al., 2000; Grassi et al., 1999; Perez et al., 2005; Roberts, Ciesla,
Direnfeld, & Hewitt, 2001). In addition, it is likely that depression is higher among
HIV+ individuals because it is idiopathic and comorbid with the risk factors that lead to
HIV infection, such as substance abuse and risky sexual behaviors (Bing et al., 2001;
Dausey & Desai, 2003). In other words, depression may be a risk factor for contracting
HIV and therefore precede actual infection. Gorman and colleagues (2009) suggest that a
bidirectional relationship may exist whereby symptoms of idiopathic depression
precipitate secondary factors such as poor psychosocial, medical and financial adjustment
in individuals with HIV. Overall, a majority of the research postulates that depression is
generally not caused by biological factors associated with HIV infiltration, but is rather
idiopathic and/or a psychological response to the cognitive deficits and social stressors
secondary to HIV.
HIV and Apathy
Apathy refers to a state of indifference and a reduction in self-initiated or goal
directed thoughts and behaviors; it is frequently seen in CNS disorders that disrupt
frontal-subcortical connections (Marin, 1991; van Reekum, Stuss & Ostrander, 2005).
Specifically, apathy includes decreased work motivation, decreased social involvement,
anhedonia, difficulty making decisions, and anergia. Apathy has been more commonly
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reported in patients infected with HIV than in the general population (Castellon et al.,
2000; Hinkin, Castellon, Atkinson & Goodkin, 2001; Rabkin et al., 2000). Because
patients with depression often have symptoms of apathy, it is difficult to distinguish
apathy as a distinct syndrome or merely a symptom of depression (Levy et al., 1998).
Nevertheless, apathy has been demonstrated to be qualitatively distinct from depression
in HIV+ individuals (Castellon et al., 2006; 1998; Levy et al., 1998). Research
conducted with the HIV population has found symptoms of apathy rather than depression
to correlate strongly with cognitive dysfunction (Castellon et al., 2006; Cole et al., 2007).
In other words, apathy, unlike depression, may reflect a direct consequence of the HIV
infection on the brain structures that regulate emotional reactivity. It can be assumed that
damage to the frontal area due to HIV infiltration has the potential to produce an
apathetic state because this is the area of the brain involved in emotional experiences
such as energy, enthusiasm, productivity, and initiative (Cummings, 1993; Levy et al.,
1998; Zamboni, Huey, Krueger, Nichelli, & Grafman, 2008). Frontal lobe symptoms
such as apathy have been attributed to disruption in subcortical circuits involving the
basal ganglia and the frontal lobes (Landes, Sperry, Strauss, & Geldmacher, 2001).
Therefore, manifestation of simultaneous apathy and cognitive deficits could be related to
the underlying damage of subcortical and frontal systems.
The relationship of apathy to neurocognitive function has been extensively
studied in a range of brain disorders (van Reekum et al., 2005). Research has shown
apathy to be separate from depression and associated with neurocognitive impairment
and neurological pathology seen in stroke, dementia, and Parkinson’s Disease
populations (Brodaty et al., 2005; Engelborghs et al., 2006; Kuzis, Sabe, Tiberti,
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Dorrego, & Starkstein, 1999; Levy et al., 1998; Oguru, Tachibana, Toda, Okuda, & Oka,
2010; Pluck & Brown, 2002). Among these brain disorders, there are a number of
studies finding a consistent relationship between high levels of apathy and poor
performance on tests representing executive function (Andersson & Bergedalen, 2002;
McPherson, Fairbanks, Tiken, Cummings, & Back-Madruga, 2002; Zgaljardic et al.,
2007). There is also research showing a relationship between apathy and executive
functioning in populations with psychosis (Faerden et al., 2009). In the Alzheimer’s
Disease (AD) population, apathy is a common neuropsychiatric symptom and one of the
primary neuropsychiatric manifestations of frontal system dysfunction (Boyle & Malloy,
2004). Cole and colleagues (2007) postulate that because AD and HIV populations have
similarly elevated rates of apathy and irritability symptomatology, it further supports the
theory that frontal system involvement is underlying the psychiatric manifestations in
both populations.
Research focusing on HIV populations suggests that apathy prominence among
HIV+ individuals may signify disease associated CNS insult. In the HIV population,
disturbance of motivation and goal-directed behavior has been found to correlate with
lower neurocognitive performance (Andersson & Bergedalen, 2002; Castellon et al.,
1998, 2000, 2006; Cole et al., 2007; Paul et al., 2005a). Castellon et al. (2006) found
prominent symptoms of apathy and irritability to be highly related to poorer performance
on neuropsychological tasks most dependent upon executive functioning. Paul and
colleagues (2005a) similarly found that higher levels of apathy correlated with poor
frontal systems functioning such as cognitive flexibility. Neuro-imaging research has
provided further preliminary evidence that apathy reflects direct involvement of the CNS
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in patients with HIV (Hoare et al., 2010; Paul et al., 2005b). Paul and colleagues (2005b)
found that increased ratings of apathy were significantly correlated with lower volume of
the nucleus accumbens, a subcortical brain structure that regulates initiation of behavioral
activation. All together these findings suggest that symptoms of apathy are likely
attributable to the primary CNS effects of the HIV virus on frontal-subcortical circuits.
Despite significant research on apathy and neurocognitive functioning in brain disorders,
there is a lack of research in this area focusing on the HIV population and even less
research focusing on older HIV+ individuals. If apathy is a potential indicator of CNS
pathology in medical illness, it is important to assess its presence and its correlates in
aging HIV individuals.
Beck Depression Inventory II
The current study focused on the “apathy” items of the second revised version of
the Beck Depression Inventory (BDI-II; Beck et al., 1996). The BDI-II was developed
for the assessment of depressive symptoms that correspond to the Diagnostic and
Statistical Manual of Mental Disorders-IV (DSM-IV; APA, 1994) criteria for major
depressive disorder. Although the BDI-II is meant to measure the global construct of
depression, the question as to whether meaningful groups of items in the questionnaire
can be discerned through factor analysis has been of ongoing interest (Beck et al., 1996).
Studying the factors that underlie the depression construct is important because recent
research indicates that sub-dimensions of depression have different correlates (Vanheule,
Desmet, Groenvynck, Rosseel, & Fontaine, 2008).
Castellon and colleagues (2006) conducted a factor analysis of the BDI on a large
sample of HIV-infected individuals and found that certain items of the depression rating
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scale consistently clustered together to form meaningful factors. Specifically, they found
three factors that were labeled Mood-Motivation Disturbance, Self-Reproach, and
Somatic Disturbance. Interestingly, these factors were found to be differentially
associated with cognitive function in their HIV/AIDS sample. The Self-Reproach factor
contained items representing negative cognitions. The Mood-Motivation Disturbance
factor contained items related to apathy, sad mood and irritability. The Somatic
Disturbance factor contained items related to somatic complaints. Specifically they
found that the Mood-Motivation Disturbance factor, which consisted of 7 items reflecting
symptoms of apathy, sad mood, and irritability, was the factor most strongly associated
with neurocognitive performance. In addition, they found that the neurocognitive
domains most closely associated with the Mood-Motivation Disturbance factor were
verbal memory, executive functioning, and motor performance. The findings indicate
that the apathy, irritability, and sad mood items from the BDI may be more indicative of
CNS dysfunction than other items. It was found that disturbance in mood and
motivation, more so than negative self-view or somatic disturbance, was related to
neurocognitive deficits.
The current study focused specifically on items within the BDI-II that were
believed to reflect symptoms of apathy. Items of interest in the current study were
comparable to only the apathy items belonging to the Mood-Motivation Disturbance
factor found in the Castellon 2006 study and found to load together in prior research on
the BDI (e.g. Startup, Rees & Barkham, 1992; Steer, Beck, Riskind, & Brown, 1987;
Tanaka & Huba, 1984). The BDI apathy related items found to load together in prior
research included (a) decreased work initiative, (b) decreased social initiative, (c)
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anhedonia, (d) difficulty making decisions, and (e) anergia. In the current study,
symptoms of sad mood and irritability were not evaluated because the researcher was
specifically evaluating the apathy component of depression. Even though the current
study examined the BDI-II rather than the original BDI, those items reflecting symptoms
of apathy have generally remained unchanged in the revised scale. The BDI was merely
modified to better complement the DSM-IV criteria for major depressive disorder (Beck,
Steer, Ball, & Ranieri, 1996). Items of the BDI-II reflective of apathy symptoms include
(a) Loss of pleasure (item 4); (b) Loss of interest (item 12); (c) Difficulty making
decisions (item 13); and (d) Loss of energy (item 15). The BDI-II item of Loss of
Interest replaced the BDI items relating to social withdrawal to emphasize withdrawal
from both interpersonal relationships and activities. In addition, the BDI-II item of Loss
of Pleasure replaced the BDI items related to loss of satisfaction and anhedonia. The
item related to difficulty making decisions remained unchanged.
Recent research has indicated that it is important to consider overlapping
symptoms of HIV disease and somatic symptoms of depression that can inflate scores on
depression inventory instruments (Kalichman, Rompa, & Cage, 2000). Kalichman and
colleagues (2000) found that removing somatic depression symptoms improved the
clinical utility of the BDI in an HIV+ sample. Their findings suggest that clinicians
should be cautious regarding somatic symptoms when evaluating depression scores in
people living with HIV infection. It has been suggested that somatic symptoms included
in most depression measures might be indicators of physical illness, and therefore,
diagnostically ambiguous (Castellon et al., 1998). Castellon and colleagues (1998)
argued that unlike the somatic symptomatology of depression, the affective/cognitive
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symptomatology of depression is a more accurate indicator of mood disturbance among
medically ill individuals. Therefore, in the current study, somatic symptoms overlapping
with medical illness symptoms, such as fatigue and loss of energy, were not evaluated
within the context of apathy because they were considered to be diagnostically
ambiguous in a medically ill population. Specifically, the BDI-II items of Loss of Energy
and Fatigue were not evaluated in terms of apathy. However, these items were included
in our evaluation of overall depression, because somatic symptoms are a significant
component of depression.
Overall, prior research has shown that while apathy and depression are
overlapping dimensions, they can nevertheless be distinguished from one another and can
differentially influence cognitive functioning (Castellon et al., 2006, 1998). However,
among HIV patients, it remains unclear whether the symptoms of apathy within
depression reflect a direct effect of the virus on subcortical brain circuits or reflect more
of a secondary neuropsychiatric manifestation.
Purpose of the Study
Many studies have failed to find a consistent relationship between mood and
neurocognitive performance among HIV+ individuals (e.g., Bornstein et al., 1993b;
Hinkin et al., 1992; von Giesen et al., 2001). However, most studies to date have focused
on depression rather than more specific and differentiated components of depression such
as apathy. In addition, those few studies that have focused on apathy in HIV populations
have studied relatively young persons. Prior research has yet to focus on the relationship
between apathy and cognition in a sample of older HIV+ individuals. The aim of the
current study was to expand on the prior research on apathy in HIV populations and
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improve our understanding of apathy in relation to executive functioning in older HIV+
individuals. This study explored the concept of mood disturbance in HIV populations by
breaking down a traditional measure of depression (BDI-II) and examining the items
believed to be reflective of apathy, including their relationship to executive functioning.
To the researcher’s knowledge, no prior research existed that utilized the BDI-II to
explore apathy symptomatology and its relationship to cognitive functioning in an older
HIV+ population or any other population. This study aimed to determine whether
specific BDI-II items representing symptoms of apathy could be clustered into a
component of depression analogous to apathy and whether executive functioning
performance would differ between those scoring high and low on this cluster.
The following research questions and hypotheses were addressed. First, to what
extent do the apathy items of the BDI-II group together in a sample of older HIV+
individuals? It was hypothesized that the BDI-II apathy items would cluster together
with an internal consistency of .70 or higher. Next, how do the BDI-II apathy items
relate to executive functioning performance in older HIV+ individuals? It was
hypothesized that persons scoring high on the apathy items would perform more poorly
on executive function tasks than persons scoring low on the apathy items. In other
words, it was predicted that scores on the BDI-II apathy cluster would be inversely
related to executive functioning performance. The third research question was as
follows: what is the relationship of BDI-II total scores to executive functioning
performance in older HIV+ individuals? It was expected that overall BDI-II scores
would have an inverse relationship to executive functioning, but the association was
expected to be weaker than that shown with the four BDI-II apathy items.
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Method
Design
This study was a secondary analysis of primary data gathered from an ongoing
longitudinal, case-control study aiming to determine the effect of age on
neuropsychological performance in HIV+ persons. The nature of the design was
essentially correlational in that the researcher examined the extent to which one factor,
i.e., the apathy items on the BDI-II, corresponded to aspects of executive functioning in a
sample of older HIV+ persons.
Participants
Subjects for this study were recruited from the West Los Angeles Veterans
Administration Medical Center and other community agencies and medical centers in the
Los Angeles area specializing in serving HIV-infected individuals. Patients were eligible
for the parent study if they were between the ages of 18-40 years or 50 years and older.
In addition, participants had to document presence or absence of HIV infection
(depending on their group assignment) and had to be proficient in English. Any
participants showing evidence of opportunistic infection or central nervous system (CNS)
infection other than HIV were excluded. In addition, participants were excluded if they
had a history of traumatic brain injury with loss of consciousness greater than 30 minutes,
a current diagnosis of seizure disorder, or a current psychotic spectrum disorder (e.g.,
schizophrenia, bipolar disorder). Patients meeting inclusion criteria were scheduled for
an initial visit. All subjects were tested as outpatients. Approval to conduct the original
study was granted by the University of California, Los Angeles and the Veteran’s
Administration Institutional Review Boards.
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Additional exclusion criteria were utilized for the present study. Subjects were
excluded if they were under the age of 50. Subjects were also excluded if they presented
with medical co-morbidities unrelated to HIV, which may increase risk for cognitive
impairment (e.g., brain anoxia, stroke). In addition, we excluded participants who tested
positive for cocaine or amphetamines on their initial visit urine screen and simultaneously
met criteria for drug dependence over the last 30 days according to self-report. These
exclusion criteria were utilized to ensure a clean sample of older HIV+ individuals. In
other words, the researcher was attempting to control for factors other than apathy that
could account for variance in cognitive performance. The researcher was aware that this
would impact generalizability, given that HIV+ individuals often possess a number of the
comorbid conditions listed in our exclusion criteria. However, the aim of this study was
to determine whether apathy, in the absence of other influential factors, could be found to
be associated with deficits in executive functioning. Given the assumption of a medium
effect size, a sample size of 64 total was determined to be sufficient to detect the presence
of significant differences at an alpha level of 0.05 (Cohen, 1992)
Neurocognitive Measures
In the current study, four instruments were used to measure executive functioning.
The Stroop Color Word Interference Test (Stroop, 1935) assesses multiple functions
including color-naming and word-reading speed, sustained attention, and, in the
interference condition, selective attention and the ability to inhibit a habitual response in
favor of a more over learned response. It is an overall measure of selective attention and
cognitive flexibility. The current study utilized the Golden version of this test (Golden,
1978). In the color-word interference condition the subject reads the color in which color
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names are printed and disregards their verbal content. The dependent variable of interest
is the number of trials completed in 45 seconds for this color-word interference condition.
High test-retest reliability coefficients have been reported for the Golden version of the
Stroop (Connor, Franzen, & Sharp, 1988; Franzen, Tishelman, Sharp, & Friedman,
1987). In addition, it has been found that the interference score correlates moderately
well with other measures of attention (MacLeod & Prior, 1996; Weinstein, Silverstein,
Nader, & Turnbull, 1999) and neuroimaging studies have shown that the frontal lobe is
the most consistent region of activation during this test (Brown et al., 1999; Mead et al.,
2002).
The Trail Making Test (Reitan, 1958) is a brief test of visual-motor function,
attention, and psychomotor speed. Part B of this task requires switching conceptual set
(alternating between connecting numbers and letters in ascending sequence) and
measures number-letter switching ability. This test has been shown to be a valid measure
of cognitive impairment (Bradford, 1992; Gaudino, Geisler & Squires, 1995) and to have
high interrater reliability (Fals-Stewart, 1992). For this particular study, only Part B
performance was examined and the dependent variable of interest was the completion
time in seconds for Part B. This test indicates one’s ability to execute and modify a plan
of action, and has been found to be sensitive to frontal lobe damage (Boll, 1981; Lezak,
Howieson & Loring, 2004). Studies have found that cognitive flexibility, also referred to
as “attentional set-shifting,” could capture executive abilities underlying Part B
performance (Chaytor, Schmitter-Edgecombe, & Burr, 2006; Kortte, Horner, &
Windham, 2002).
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The Controlled Oral Word Association Test (Benton, Hamsher, Varney & Spreen,
1983) assesses semantic and phonemic verbal fluency. Over the course of three, oneminute trials, the subject must name as many words as he or she can starting with a given
letter (“F”, “A”, and “S”) and, in the final one-minute trial, he or she must name as many
types of animals as possible. This test has been shown to have high test-retest reliability
(Levine, Miller, Becker, Selnes, & Cohen, 2004), high interrater reliability (Ross, 2003)
and good validity (Troyer, 2000). In the current study, only phonemic (FAS)
performance was examined and the dependent variable of interest was the total number of
words generated. The verbal fluency test has been described as an executive function test
(Lezak et al., 2004). Moreover, research has shown that patients with frontal damage
produced significantly fewer responses on verbal fluency tests compared with patients
with lesions in other brain areas (Perret, 1974).
The Wisconsin Card Sorting Test (WCST; Grant & Berg, 1948) is widely
regarded as a valid test of frontal lobe functioning (Robinson, Heaton, Lehman, &
Stilson, 1980; Lezak et al., 2004) with generally strong test-retest reliability (Tate,
Perdices, & Maggiotto, 1998). The WCST assesses abstract reasoning, problem solving
and the ability to adapt cognitive strategies to external changing feedback (Chelune &
Baer, 1986). The dependent variable of interest in the current study was the number of
perseverative errors on the WCST-64 computer version of this test - an abbreviated form
of the standard 128-card version of the WCST (Kongs, Thompson, Iverson, & Heaton,
2000). A perseverative error refers to the number of errors in which the participant
perseverates on a prior matching strategy, reflecting failure to shift to the new sorting
criterion. Among the various scoring norms of the WCST, perseverative errors are
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regarded as the main signs of frontal dysfunction (Greve, Stickle, Love, Bianchini, &
Stanford, 2005).
Neuropsychiatric Measure
The Beck Depression Inventory, 2nd Edition (BDI-II; Beck et al., 1996), a 21-item
self-report rating scale containing questions pertaining to the presence and intensity of
various cognitive, affective, and somatic symptoms of depression over a two-week
period, was administered to all participants. Each item is a list of four statements
arranged in increasing severity about a particular symptom of depression. There is a
four-point scale for each item ranging from 0 (symptom absent) to 3 (presence of
symptom is pronounced). Each of the 21 items is summed to give a single score for the
BDI-II. Cut score guidelines for the BDI-II are as follows: Total score of 0-13 is
considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe. The
timeframe and items are aligned with depression criteria of the DSM-IV. The test
requires a 5th to 6th grade reading level (Groth-Marnat, 2009) and is intended for persons
13 years of age and older. According to test authors, the BDI-II demonstrated internal
consistency reliability of .92 in a sample of 500 psychiatric patients, and test-retest
reliability (one week interval) of .93 in a small sample of outpatients (Beck et al., 1996).
Evaluations of the content, concurrent, and discriminant validity of the BDI-II have been
impressive, and over 1,000 research studies have employed a version of the Beck
Depression Inventory (Groth-Marnat, 2009).
Research has indicated that the BDI-II is a reliable and valid measure of
depression for use in outpatient medical populations, including among ethnically and
socioeconomically diverse communities (e.g., Jarjoura et al., 2004; Joe, Woolley, Brown,
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Ghahramanlou-Holloway, & Beck, 2008; Groth-Marnat, 2009; Grothe et al., 2005). It
has also been used with diverse samples of HIV+ individuals (e.g., Weiser et al., 2006)
and has been found to be a sufficiently reliable and valid measure for assessing
depression in an HIV positive sample (Lipps et al., 2010). Therefore, the BDI-II was
determined be an appropriate measure of depressive symptoms in the present sample.
The apathy variable of interest in the current study consisted of the following
items of the BDI-II: (a) Loss of Pleasure (item 4); (b) Loss of Interest (item 12); (c)
Indecisiveness (item 13); and (d) Loss of Interest in Sex (item 21). To the researcher’s
knowledge, there had been no published research attempts to examine the apathy items of
the BDI-II prior to the current study. Therefore, the current study aimed to look
specifically at items that were comparable to those items previously found to load
together in the original BDI and to be reflective of disturbance in motivation (Castellon et
al., 2006; Startup et al., 1992; Steer et al., 1987; Tanaka & Huba, 1984). Five of the
seven original BDI items in the Mood-Motivation Disturbance factor identified by
Castellon and colleagues (2006) appeared reflective of apathy. Those items addressed
included decreased work initiative, decreased social initiative, anhedonia, difficulty
making decisions, and anergia. Those items appeared similar to items found on
established apathy scales (e.g., The Apathy Evaluation Scale-Self Report Version; Marin,
1991). In the current study, somatic symptoms overlapping with medical illness
symptoms, such as fatigue and loss of energy, were not evaluated within the context of
apathy because they were considered to be diagnostically ambiguous in a medically ill
population. Items of interest were cognitive-affective and directly correspond to the
“apathy” items found in previous research on the BDI. Therefore, items reflective of the
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anergia item from the earlier BDI research were not included among the apathy-related
BDI-II items selected for study in the present investigation. Loss of Interest in Sex was
included in the present “apathy” construct because it inquires about interest in sexual
activity rather than changes in sexual activity.
Procedures
All participants completed a comprehensive neuropsychological test battery
between the years of 2005 and 2010 at the West Los Angeles Veterans Administration
Medical Center. The battery was administered by trained psychometrists who were
supervised by a board certified neuropsychologist. The neuropsychological evaluation
was extensive and included multiple performance measures of several cognitive domains.
Participants’ sociodemographic data, HIV status and health information (e.g., viral load,
CD4 count, medications, duration of illness, and health conditions) were obtained once
informed consent had been established. Participants completed all screens,
questionnaires, and neuropsychological tests within a one-day period. Initial visit
duration was typically 6-7 hours and participants were financially compensated $90.00 at
the end of the day.
The current study examined a sub-sample of Visit 1 data that included
neurocognitive test results, specifically in the domain of executive functioning, as well as
BDI-II scores, and demographic information. The current study only examined the older
age group (older > 50 years). Neurocognitive test scores were converted to
demographically adjusted T-scores (M = 50, SD = 10), including adjustments for age,
education, gender, and ethnicity as available for each test. In other words, when
demographic specific norms were available for a test, T-scores were calculated based on
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comparisons to norm groups that shared similar demographic characteristics.
Specifically, scores obtained from the Trails B and FAS tests were corrected based on
age, education, gender and race/ethnicity (Heaton, Miller, Taylor, & Grant, 2004).
Scores obtained from the WCST-64 were adjusted based on age, education, gender and
race/ethnicity (Kongs et al., 2000). Scores for the Stroop C test were demographically
adjusted for age only (Golden, 1978). The T-scores of tests expected to represent
executive functioning were averaged into one score that was meant to reflect the
construct or variable, “executive function”. The researcher was granted approval from
Pepperdine University’s Graduate and Professional Schools Institutional Review Board
(GPS IRB) subsequent to submitting the proposal for consideration and review.
Data Process and Analysis
The Statistical Package for the Social Science (SPSS) version 18.0 was used for
all data analyses. For the first research question, a Cronbach’s alpha reliability analysis
was conducted to determine whether the four apathy items of the BDI-II would cluster
together into a component that could reasonably and meaningfully be viewed as
representing apathy. An internal consistency value of 0.7 or higher was expected to
indicate that these items adequately cluster together. This cluster of BDI-II items was
summed and labeled as “Apathy”. For the second research question, the researchers
divided the sample into two groups labeled “Low Apathy” and “High Apathy”. In an
effort to maximize apathy differences, the original plan was for the groups to be
dichotomized by their Apathy scores as follows: Low Apathy < 33rd percentile; High
Apathy > 67th percentile. Those individuals scoring between the two cut-offs were not to
be included in the analysis. This was expected to allow sufficient discrimination to
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adequately differentiate between the Low and High Apathy groups. Excluding those
individuals scoring between the 33rd and 67th percentile was meant to control for the
ambiguity that arises when creating groups based on cut-off scores or median splits. As
is described in the Results chapter, the cut-offs had to be adjusted to fit the obtained data.
The executive function variable of interest in the current study consisted of the
average of T scores from the four chosen “executive function” measures. A one-way
ANOVA was run to determine whether the High Apathy group had significantly lower
executive functioning performances than the Low Apathy group. For the final research
question, we divided the sample into two groups based on a cluster of total BDI-II items.
We labeled these two groups “Low Depression” and “High Depression”. In an effort to
maximize depression differences, the original plan was for the groups to be dichotomized
by their BDI-II total scores as follows: Low Depression < 33rd percentile; High
Depression > 67th percentile. Those individuals scoring between the two cut-offs were
not to be included in the analysis. As described in the Results chapter, the cut-off had to
be adjusted slightly for the Low Depression group in order to better fit the present data.
A one-way ANOVA was run to determine whether the High Depression group had
similar executive function scores compared to the Low Depression group. Finally,
correlations were calculated to assess the relationships between executive functioning
performance and each of the three components of the BDI-II that were being examined
(e.g. Apathy, Non-Apathy, Depression). To determine the correlations between normally
distributed continuous variables, Pearson’s r was utilized.
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Results
The total sample consisted of 95 individuals. As can be seen in Table 1 and Table
2, on average, the participants who met the inclusion criteria were 55.26 years old (SD =
5.85), had a lowest CD4 count of 191.04 (SD = 198.11) and had an educational level of
13.67 years (SD = 2.20). On the Wechsler Test of Adult Reading (WTAR; The
Psychological Corporation, 2001), a reading test that estimates pre-morbid level of
intellectual functioning, the participants had a mean standard score of 97.73 (SD =
17.19), reflecting an average performance. Table 3 presents the mean values on measures
of executive functioning. Consistent with the WTAR finding, participants obtained an
overall mean T score of 45.33 (SD = 9.25) on the executive functioning measures,
indicating that performance fell in the average range.
As indicated in Table 2, the sample was diverse in terms of ethnicity and sexual
orientation. The following frequencies were obtained regarding ethnicity: African
American (n = 52), Caucasian (n = 30), Hispanic (n = 10), and Biracial (n = 1). In regard
to sexual orientation, the participants self-identified as follows: heterosexual (n = 43),
homosexual (n = 37) and bisexual (n = 15). A majority of the sample had low levels of
household income: less than $12,000 (n = 51); $12,000 to 49,999 (n = 35); $50,000 or
more (n = 7). A majority of participants were male (n = 80) and reported English as their
first language (n = 85). All participants were proficient in English and were positive for
HIV.
The mean Apathy score of the sample was 2.21 (SD = 2.17) with Apathy scores
ranging from 1 to 8. The mean BDI-II score of the sample was 10.22 (SD = 8.67) with
scores ranging from 0 to 35. Using the cut-off scores empirically established by Beck
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and colleagues (1996), approximately 72% of the sample scored in the range considered
as non-depressed (0-13), 11.6% in the range considered mild depression (14-19), 13% in
the range considered moderate depression (20-28) and 3.3% in the range labeled as
severe depression (29-63).
A Cronbach’s alpha reliability analysis was conducted to determine whether the
chosen four apathy items of the BDI-II clustered together into a component that could
reasonably viewed as representing apathy. Analysis determined that these items did
cluster together with a value greater than 0.7 (α = 0.748).
In order to dichotomize the low apathy and high apathy groups, our plan was to
use 33rd/67th percentile cutoffs to adequately differentiate between the groups. Of the
sample, 48.9% (n = 46) had an Apathy score of 1 or lower (M = 0.41, SD = 0.5) and met
our revised cut-off criterion for the Low Apathy group while 39.5% (n = 37) of the
sample had an apathy score of 3 or higher (M = 4.51, SD = 1.5) and met our revised cutoff criterion for the High Apathy group. The mean apathy score for the Low Apathy
group was 0.41 (SD = .5) and the mean apathy score for the High Apathy group was 4.5
(SD = 1.5). It was examined whether the High Apathy group differed from the Low
Apathy group in terms of executive functioning performance. We used an alpha level of
0.05 for all statistical tests. As can be seen in Table 4, a one-way ANOVA, comparing
the High Apathy and Low Apathy groups revealed that the High Apathy subjects were no
more impaired on the executive functioning measures (M = 44.87, SD = 9.17), than were
Low Apathy subjects (M = 45.59, SD = 10.03), t(1,80) = 0.11, p = 0.74. Therefore, the
hypothesis that higher levels of apathy would be associated with greater impairment in
executive functioning was not supported.
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As can be seen in Tables 5 and 6, the Low Apathy and High Apathy groups did
not differ significantly in age, lowest T-cell counts or educational level, and gender,
income and ethnicity distributions were roughly equivalent. Of note, a difference right at
the threshold of statistical significance was found in pre-morbid intelligence as measured
by the WTAR with the High Apathy subjects having a lower WTAR standard score (M =
93.49, SD = 18.61) than the Low Apathy subjects (M = 101.16, SD = 16.08), t(1,79) =
3.96, p = 0.05.
A Cronbach’s alpha reliability analysis was conducted to establish the internal
consistency of the BDI-II with the present sample. The analysis confirmed a high level
of internal consistency reliability (α = 0.92), similar to the values reported in the BDI-II
manual (Beck et al., 1996). In order to dichotomize the low depression and high
depression groups, our plan was to use 33rd/67th percentile cutoffs to differentiate the
between the groups. Of the sample, 31% (n = 30) had a BDI-II score of 4.0 or lower (M
= 1.90, SD = 1.49) and met our revised cut-off criterion for the Low Depression group,
while 33% (n = 31) had a BDI-II score of 12 or higher (M = 20.39, SD = 6.37), and met
our cut-off criterion for the High Depression group. It was examined whether the High
Depression group differed from the Low Depression group in terms of executive
functioning performance. As can be seen in Table 7, a one-way ANOVA, comparing the
High Depression and Low Depression groups, revealed that the High Depression subjects
were no more impaired on the executive functioning measures (M = 45.32, SD = 9.49),
than were Low Depression subjects (M = 44.09, SD = 10.95), t(1,59) = 0.22, p = 0.64.
To determine whether apathy and depression scores might be differentially
associated with executive functioning performance in HIV-infected adults, we calculated
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Pearson’s r correlations between three different BDI-II scores (apathy items, total score,
and non-apathy related items) and the composite score of executive function. As can be
seen in Table 7, and contrary to what the researcher expected, neither apathy nor overall
depression scores were significantly correlated with executive functioning performance.
Specifically, the correlations between executive functioning and the four-item BDI-II
apathy cluster (r = -0.02) and between executive functioning and the total BDI-II score (r
= 0.04) were not significant. Moreover, non-apathy depression items from the BDI-II
were also found to be unrelated to the executive function variable (r = 0.03).
Additional Analysis
The HIV+ individuals (n = 9) who were excluded from the present study were
analyzed to determine whether those individuals had greater cognitive impairment and/or
mood symptoms compared to the individuals who met inclusion criteria. The mean
Apathy score of the exclusion group was 2.33 (SD = 2.00) with Apathy scores ranging
from 0 to 6. The mean BDI-II score of this group was 12.67 (SD = 9.95) with scores
ranging from 0 to 29. On the executive functioning measures, these individuals obtained
an overall mean T score of 45.50 (SD = 9.48), reflecting a performance falling in the
average range. These data are similar to those of the inclusion group indicating that the
HIV+ persons excluded from the sample were no more cognitively impaired or
neuropsychologically symptomatic than individuals who met the study’s inclusionary
criteria.
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Table 1
Demographic Characteristics of Total Sample (N = 95)
Total Sample
Variable
Mean
Age
55.26
Education
13.67
Lowest CD4 Count
191.04
Apathy Score
2.21
Depression Score
10.23
WTAR Standard Score
97.73
Table 2
Demographic Characteristics of Total Sample (N = 95)
N
Ethnicity
American Indian/Alaskan
1
Asian/Pacific Islander
1
Black
52
Hispanic
10
White
30
Other/Multiracial
1
Sex
Male
80
Female
15
English as First Language
No
10
Yes
85
Sexual Orientation
Heterosexual
43
Homosexual
37
Bisexual
15
Household Income
Less Than $6,000
13
$6,000 to $11,999
38
$12,000 to $24,999
27
$25,000 to $49,999
8
$50,000 or more
7
Refused To Answer
1
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SD
5.85
2.20
198.11
2.17
8.67
17.19

%
1.05
1.05
54.74
10.52
31.58
1.05
84.21
15.79
10.53
89.47
45.26
38.95
15.79
13.68
40
28.42
8.42
7.37
1.05

Table 3
Executive Function Test Scores of Total Sample (N = 95)
Total Sample
Variable
Mean
Executive Function Score
45.33
Trails B
45.84
FAS Total
48.54
Stroop Color/Word
44.23
WCST 64 Perseverative
46.13
Errors

SD
9.25
12.92
11.00
8.56
10.34

Table 4
Executive Function Score Means for Low Apathy (n =46) and High Apathy (n = 37)
Subjects
Apathy
Low
High
F
Sig
Executive
45.59
44.87
0.11
0.74
Function Score
(10.03)
(9.17)
Trails B
47.04
44.56
.70
.40
(14.11)
(12.15)
FAS Total
49.31
47.61
.46
.50
(12.19)
(9.95)
Stroop Color/Word
43.30
45.11
.86
.36
(7.63)
(9.71)
WCST 64
46.70
45.92
.11
.74
Perseverative
(12.19)
(8.13)
Errors
Standard deviations appear in parentheses below means.
Table 5
Demographic Characteristics of Low Apathy (n = 46) and High Apathy (n = 37) Subjects
Apathy
Low
High
F
sig
Age
56.78
54.32
3.46
0.07
(7.27)
(3.80)
Education
13.78
13.57
.18
.67
(2.32)
(2.21)
Lowest CD4
218.86
170.67
1.18
.28
(220.63)
(164.21)
WTAR Standard
101.16
93.49
3.96
0.05
Score
(16.08)
(18.61)
Standard deviations appear in parentheses below means.
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Table 6
Demographic Characteristics of Low Apathy (n = 46) and High Apathy (n =37) Subjects
Low Apathy
High Apathy
N
%
N
%
sig
Ethnicity
.625
American
0
0
1
2.7
Indian/Alaskan
Asian/Pacific
0
0
1
2.7
Islander
Black
26
56.52
19
51.35
Hispanic
4
8.7
4
10.81
White
15
32.61
12
32.43
Other/Multiracial
1
2.17
0
0
Sex
.451
Male
39
84.78
29
78.38
Female
7
15.22
8
21.62
Sexual Orientation
Heterosexual
20
43.48
20
54.05
.56
Homosexual
18
39.13
13
35.14
Bisexual
8
17.39
4
10.81
Household Income
Less Than $6,000
5
10.87
6
16.67
.13
$6,000 to $11,999
23
50
10
27.78
$12,000 to
11
23.91
14
38.89
$24,999
$25,000 to
1
2.17
4
11.11
$49,999
$50,000 or more
5
10.87
2
5.56
Refused To
1
2.17
0
0
Answer
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Table 7
Executive Function Score Means for Low Depression (n =30) and High Depression (n
=31) Subjects
Depression
Low
High
F
sig
Executive
44.09
45.32
0.22
0.64
Function Score
(10.94)
(9.49)
Trails B
44.83
46.47
.29
.59
(13.80)
(10.17)
FAS Total
48.91
47.67
.19
.66
(12.40)
(10.42)
Stroop Color/Word
42.21
44.73
1.33
.25
(7.57)
(9.73)
WCST 64
43.85
46.90
1.49
.23
Perseverative
(10.83)
(9.03)
Errors
Standard deviations appear in parentheses below means.
Table 8
Correlations between the Mean Executive Function Score and the BDI-II Apathy, NonApathy-Related Items, and Overall Depression Scores (N = 95)
Executive Function Score
Apathy Items
Pearson’s Correlation
-0.02
Sig. (2-tailed)
.87
Non-Apathy Items

Pearson’s Correlation
Sig. (2-tailed)

0.04
0.7

Overall BDI-II Depression

Pearson’s Correlation
Sig. (2-tailed)

0.03
0.77
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Discussion
Overview
The present study sought to examine the relationship between apathy and
executive functioning among HIV-infected adults. Additional but related aims were to
examine whether specific items of the BDI-II thought to be reflective of apathy would
cluster together, and whether there would exist an association between that cluster score
and executive functioning performance in a sample of HIV-infected persons. Although
apathy in relation to neurocognitive functioning has been evaluated among HIV
populations (Anderson & Bergedalen, 2002; Castellon et al., 1998, 2000, 2006; Cole et
al., 2007; Paul et al., 2005a), this appeared to be the first study to focus on an older
population and to specifically examine individual items of the BDI-II thought to be
related to apathy.
Internal Consistency of BDI-II Apathy Items
We hypothesized that the chosen BDI-II items representing apathy would cluster
together, and those endorsing a higher number of these items would have lower executive
functioning scores compared to those endorsing a lower number of apathy items. The
results supported the hypothesis that the BDI-II apathy items would cluster together with
an internal consistency of .70 or higher. While this was an encouraging finding, it must
be noted that the entire BDI-II has a high level of internal consistency. In fact, the
overall internal consistency of the BDI-II was approximately .92 in the present sample.
Therefore, the encouraging level of internal consistency among the four items selected
for study could not be viewed as definitive evidence that those four items were in fact
measuring the construct of apathy. A limitation of the present study, which is discussed
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further later in this chapter, was that there was no independent measure of apathy that
could be utilized to confirm the extent to which the four BDI-II items represented an
adequate measure of the construct of apathy.
Relationship of BDI-II Apathy Items to Executive Functioning
The central hypothesis that persons scoring higher on the apathy items would
perform more poorly on executive functioning tasks than persons scoring lower on the
apathy items was not supported. Inconsistent with our hypothesis, we found that there
was no difference in executive functioning performance between those scoring high on
our apathy construct and those scoring low on this construct. Therefore, these results do
not support the proposition that there is an aspect of depression, similar to apathy and
measured by four items from the BDI-II, which is involved with frontal lobe neurological
functioning (as measured by neurocognitive tests of executive functioning). Moreover,
correlational analysis likewise revealed there was no significant relationship between our
four apathy items and executive functioning in the present sample.
Relationship of BDI-II to Executive Functioning
Data analysis revealed that there was no significant relationship between BDI-II
total scores and executive functioning performance in the present sample. In other
words, we did not find a relationship between depressive symptoms and executive
functioning. Overall, the sample demonstrated average intellectual functioning, over 13
years of mean education, and relatively low levels of depressive symptoms as measured
by the BDI-II. Overall, the present sample was relatively healthy, apparently high
functioning, and generally symptom free, both in regard to cognitive and emotional
functioning. Additional analyses showed similar levels of health and well-being among
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the nine HIV+ individuals who were excluded from participation in the study. This
indicated that the lack of neuropsychological symptomatology in our sample was not a
mere consequence of the exclusionary criteria applied in the current study. Moreover, the
mean age of the sample was approximately 55 and therefore it may be that many
individuals in the present sample were not yet old enough or had not been HIV+ long
enough to begin to experience significant sequelae in regard to cognitive or emotional
functioning.
Another possibility is that the persons in the present sample were actively
pursuing treatment regimens that were in fact yielding health benefits, both cognitively
and emotionally. The low prevalence of moderate to severe depression (16.3%) and the
average executive functioning performance scores found in our HIV+ sample may reflect
the advances of HIV care in the post-HAART era. Moreover, our sample was found to
be relatively healthy, with an average CD4 count of 190. The sample showed less
immune system compromise than found in previous studies of HIV+ individuals,
suggesting that perhaps their disease processes and/or symptoms are being effectively
managed. The relatively high level of functioning within our sample could therefore
represent evidence of the positive outcomes related to HIV treatment advances. It may
also be that in our sample of relatively healthy, middle-aged HIV+ persons, any cognitive
deficits that did exist may have been too subtle to detect with the methods used in the
current study.
Limitations
Overall, we did not find any significant association between apathy and executive
functioning in a sample of HIV+ individuals. This is in contrast to findings by Castellon
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and colleagues (2000; 2006) and other recent research showing a relationship between
cognitive impairment and symptoms of apathy in neurologically impaired populations
(Andersson & Bergedalen, 2002; McPherson et al., 2002; Zgaljardic et al., 2007). The
reason for the absence of any significant association between apathy and executive
functioning is unclear, but may be due to the methodology employed in the present study.
Castellon and colleagues (2006) were able to break down the BDI to suggest that there is
an aspect of depression, similar to apathy, which is more likely to reflect potential
neurologic involvement. Their subset of seven BDI items was defined as a MoodMotivation Disturbance factor and it included several items reflective of apathy, as well
as items addressing sad mood and irritability. However, most other studies showing a
relationship between apathy and cognitive functioning have used independent, validated
measures of apathy, such as the Neuropsychiatric Inventory (NPI; Cummings et al.,
1994). Therefore, it is suspected that a limitation of the present study was that our apathy
variable lacked construct validity and the four BDI-II items we selected failed to
adequately capture the construct of apathy. It may be that the four BDI-II items chosen
to represent apathy in the present study accounted for too few of the many characteristics
that define true apathy. It is also possible that those items were in fact measuring
symptoms of depression rather than apathy. Our study failed to utilize an independent,
validated criterion measure of apathy to determine whether the four BDI-II items in fact
measured apathy. The results of the present study are therefore somewhat inconclusive.
Of note, there was a slight difference, right at the threshold of statistical
significance, in estimated pre-morbid intellectual functioning (i.e., WTAR scores)
between the Low Apathy and High Apathy subjects. The High Apathy subjects were
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found to have a lower mean WTAR score (93.49) than the Low Apathy group (101.16).
This finding suggests that pre-morbid intelligence may be a factor (beyond neurotropic
effects of HIV) that is related to psychiatric symptomatology such as apathy or
depression. This finding also reflects the limitation of the non-experimental archival
nature of the current study in which the researcher could not manipulate variables and
explore causal relationships. For example, it is possible that some of the psychiatric
symptoms and/or frontal/cognitive deficits were pre-existing risk factors leading to HIV
contraction, and therefore predated the HIV infection and associated neuropsychiatric
sequelae.
As mentioned, a limitation of the current study was that it only utilized the BDI-II
as a measure of depressive and apathy symptoms. The self-reported assessment of
symptoms of depression and/or apathy on the BDI-II was not corroborated by any other
assessment measures or by diagnostic interviews. In the original study, there was no
assessment of apathy or depression based on third-party informants (e.g., romantic
partners, family members, etc.). Alas, the participants may not have been fully reliable
informants in regard to their mood symptoms. It is possible that some participants may
not have been able to accurately perceive or have adequate insight to report on their
levels of apathy or depression symptoms. Of note, 72% of the sample fell in the nondepressed range. This finding was surprising and not consistent with the relatively high
prevalence of depression found among most HIV+ populations that have been studied to
date (e.g., Basu et al., 2005; Bing et al., 2001; Chandra et al., 2005; Treisman et al.,
1998). One plausible explanation for the low levels of depressive symptoms identified
within our sample was the self-report measure utilized. For example, approximately 33%
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of the current sample obtained total scores in the range of 0-4 on the BDI-II, suggesting
the possibility that some of the sample may have been denying depression, or failing to
put forth optimal effort when completing the measure. These findings therefore raise
questions about the adequacy of using only a self-report measure to assess for the
presence of symptoms of depression and apathy in a community sample of HIV+
individuals. However, the possibility that the present sample, which was relatively small,
consisted of an unusual number of persons who were in fact relatively free of depressive
symptoms must also be considered.
Another limitation was the method by which the construct of apathy was
determined for the present study. Perhaps in part because there were only four BDI-II
items utilized to represent apathy, there was a lack of variance between those groups who
scored low and those who scored high on this variable. Specifically, only 39.5% of our
sample scored in the “High Apathy” range, while 48.9% of the sample scored in the
“Low Apathy” range. Therefore, there may have been insufficient representation of High
Apathy subjects compared to Low Apathy subjects in the present sample.
A lack of statistical power may also explain why we were unable to find
differences between the Low Apathy and High Apathy groups. Because we decided to
exclude participants who recently abused substances, and split groups using approximate
33%/67% cut-offs, this yielded a relatively small sample size (n = 83), which may have
reduced the level of power for detecting executive function score differences between
Low Apathy and High Apathy individuals.
It is worth mentioning that one of the four executive function tests (i.e., Stroop C)
included in the composite executive functioning performance score was demographically
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adjusted solely based on age (Golden, 1978), due to a lack of demographic specific
norms. Therefore, the overall executive functioning score was not fully free from
potentially significant comorbid factors, including gender, ethnicity, and years of
education. Moreover, in regard to executive function scores, in the current study there
was no analysis to control for those individuals who may have substituted speed for
accuracy. Therefore, there may have been individuals who were speedy and therefore
had higher T scores, despite having made a significant number of errors. Failing to
account for such errors in our analysis may have compromised the effectiveness of our
composite score to adequately capture true executive functioning abilities.
In addition, there were a number of limitations in regards to generalizability.
First, because of the relatively small number of participants in the current study (N = 95),
the findings may not generalize to the greater population of HIV-infected patients.
Second, the data were collected in one geographic area and therefore the results may not
be generalizable to older HIV+ persons living in other settings. Third, because the
current research study examined a population of HIV+ individuals without neurological
comorbidities, the results cannot be generalized to an HIV+ population that is expected to
have a significant number of such comorbid conditions. Finally, the majority of the
subjects in the original study were men, suggesting that the results may not be fully
generalizable to women with HIV.
Conclusions and Recommendations
In summary, this study failed to find an association between a subset of BDI-II
items thought to be reflective of apathy and executive functioning in a sample of older
HIV+ individuals. However, it will be important to further investigate the relevance of
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apathy symptoms in samples of HIV-infected individuals, as well as among individuals
from other neurologically compromised populations. Based on the limitations of the
current study, it is suggested that researchers utilize validated measures of apathy in any
future research attempting to examine the relationship of apathy to cognitive functioning.
It may be that a relationship between apathy and executive functioning would be found
among older HIV+ persons if a more valid and robust measure of apathy were utilized.
For example, adaptations of the apathy subscales of the Neuropsychiatric Inventory
(NPI), developed by Cummings and colleagues (1994) and modified for use with HIVinfected subjects (Castellon et al., 1998, 2000), may be among the leading measures to be
considered for future studies. Moreover, future research should assess apathy through
multiple methods rather than rely solely upon self-report. For example, the inclusion of
ratings by clinicians and significant others may result in more comprehensive and
accurate assessments of apathy.
More research is needed on whether an apathy subscale can be identified from the
BDI-II items. The present study utilized the findings from earlier BDI research and
rational analysis to select four items as the leading candidates for an apathy subscale.
Future researchers might do well to step back and consider whether a broader or different
set of BDI-II items could be selected as more promising and valid indicators of apathy
among HIV+ persons. Future research might also benefit from the inclusion of more
HIV+ persons who display high levels of depressive symptoms, as well as more persons
demonstrating significant cognitive problems. Larger samples that have more variance
on these critical dimensions of age and functioning may shed greater light on the
relationship, if any, of apathy to executive functioning among HIV+ persons.
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Despite the lack of findings in the present study, additional research is
recommended to further investigate the relationship between the apathy component of
depression and its relationship with neurocognitive performance and neurological
functioning in an HIV+ population. Further study is needed to clarify whether
psychiatric features such as apathy may be a representative biomarker of HIV neurotropic
effects on the CNS. Understanding the connection between mood or motivation
disturbance and markers of potential CNS involvement is important as it has potential
implications for understanding the neurocognitive basis for neuropsychiatric
symptomatology. Ultimately, clarifying the connection between psychiatric
symptomatology and neurological deficits may lead to the development of more optimal
intervention efforts (e.g., neuro-protective therapies and psychopharmacological
treatment options) for HIV+ individuals presenting with neuropsychological sequela.
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